i & o med limited Company Information
Company Number
07963347
Next Accounts
Nov 2025
Industry
General medical practice activities
Shareholders
ibtihal al-jbouri
omar aldabbagh
Group Structure
View All
Contact
Registered Address
floor 2 9 portland street, manchester, M1 3BE
Website
persysmedical.comi & o med limited Estimated Valuation
Pomanda estimates the enterprise value of I & O MED LIMITED at £1.2m based on a Turnover of £3m and 0.41x industry multiple (adjusted for size and gross margin).
i & o med limited Estimated Valuation
Pomanda estimates the enterprise value of I & O MED LIMITED at £758.7k based on an EBITDA of £230.4k and a 3.29x industry multiple (adjusted for size and gross margin).
i & o med limited Estimated Valuation
Pomanda estimates the enterprise value of I & O MED LIMITED at £2.8m based on Net Assets of £1m and 2.73x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
I & O Med Limited Overview
I & O Med Limited is a live company located in manchester, M1 3BE with a Companies House number of 07963347. It operates in the general medical practice activities sector, SIC Code 86210. Founded in February 2012, it's largest shareholder is ibtihal al-jbouri with a 50% stake. I & O Med Limited is a established, small sized company, Pomanda has estimated its turnover at £3m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
I & O Med Limited Health Check
Pomanda's financial health check has awarded I & O Med Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £3m, make it larger than the average company (£1.2m)
- I & O Med Limited
£1.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (10.6%)
- I & O Med Limited
10.6% - Industry AVG
Production
with a gross margin of 23.4%, this company has a higher cost of product (45.2%)
- I & O Med Limited
45.2% - Industry AVG
Profitability
an operating margin of 7.8% make it more profitable than the average company (5.2%)
- I & O Med Limited
5.2% - Industry AVG
Employees
with 2 employees, this is below the industry average (16)
2 - I & O Med Limited
16 - Industry AVG
Pay Structure
on an average salary of £36.1k, the company has an equivalent pay structure (£36.1k)
- I & O Med Limited
£36.1k - Industry AVG
Efficiency
resulting in sales per employee of £1.5m, this is more efficient (£90.4k)
- I & O Med Limited
£90.4k - Industry AVG
Debtor Days
it gets paid by customers after 156 days, this is later than average (36 days)
- I & O Med Limited
36 days - Industry AVG
Creditor Days
its suppliers are paid after 37 days, this is slower than average (26 days)
- I & O Med Limited
26 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- I & O Med Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - I & O Med Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.7%, this is a lower level of debt than the average (53.7%)
19.7% - I & O Med Limited
53.7% - Industry AVG
I & O MED LIMITED financials
I & O Med Limited's latest turnover from February 2024 is estimated at £3 million and the company has net assets of £1 million. According to their latest financial statements, I & O Med Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | 2 | 2 | 2 | 2 | 2 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 22 | 29 | 39 | 52 | 70 | 94 | 125 | 1,064 | 1,783 | 1,346 | 1,246 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 22 | 29 | 39 | 52 | 70 | 94 | 125 | 1,064 | 1,783 | 1,346 | 1,246 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 1,266,250 | 1,102,705 | 1,011,108 | 904,150 | 494,611 | 464,130 | 323,713 | 0 | 19,466 | 31,490 | 56,494 | 4,439 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75,000 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 242,355 | 168,922 | 97,010 | 14,170 | 11,818 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,266,250 | 1,102,705 | 1,011,108 | 904,150 | 494,611 | 464,130 | 323,713 | 242,355 | 188,388 | 128,500 | 70,664 | 91,257 |
total assets | 1,266,272 | 1,102,734 | 1,011,147 | 904,202 | 494,681 | 464,224 | 323,838 | 243,419 | 190,171 | 129,846 | 71,910 | 91,257 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 234,411 | 234,255 | 306,421 | 317,238 | 70,752 | 108,935 | 42,595 | 39,398 | 32,540 | 32,650 | 14,627 | 26,938 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 234,411 | 234,255 | 306,421 | 317,238 | 70,752 | 108,935 | 42,595 | 39,398 | 32,540 | 32,650 | 14,627 | 26,938 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 15,067 | 24,468 | 33,868 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 357 | 269 | 0 | 0 |
total long term liabilities | 15,067 | 24,468 | 33,868 | 50,000 | 0 | 0 | 0 | 0 | 357 | 269 | 0 | 0 |
total liabilities | 249,478 | 258,723 | 340,289 | 367,238 | 70,752 | 108,935 | 42,595 | 39,398 | 32,897 | 32,919 | 14,627 | 26,938 |
net assets | 1,016,794 | 844,011 | 670,858 | 536,964 | 423,929 | 355,289 | 281,243 | 204,021 | 157,274 | 96,927 | 57,283 | 64,319 |
total shareholders funds | 1,016,794 | 844,011 | 670,858 | 536,964 | 423,929 | 355,289 | 281,243 | 204,021 | 157,274 | 96,927 | 57,283 | 64,319 |
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | 1,429 | 1,224 | 689 | 220 | 0 | |||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | |||||||
Tax | ||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 163,545 | 91,597 | 106,958 | 409,539 | 30,481 | 140,417 | 323,713 | -19,466 | -12,024 | -25,004 | -22,945 | 79,439 |
Creditors | 156 | -72,166 | -10,817 | 246,486 | -38,183 | 66,340 | 3,197 | 6,858 | -110 | 18,023 | -12,311 | 26,938 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -357 | 88 | 269 | 0 | 0 |
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -9,401 | -9,400 | -16,132 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | -242,355 | 73,433 | 71,912 | 82,840 | 2,352 | 11,818 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -242,355 | 73,433 | 71,912 | 82,840 | 2,352 | 11,818 |
i & o med limited Credit Report and Business Information
I & O Med Limited Competitor Analysis
Perform a competitor analysis for i & o med limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in M 1 area or any other competitors across 12 key performance metrics.
i & o med limited Ownership
I & O MED LIMITED group structure
I & O Med Limited has no subsidiary companies.
Ultimate parent company
I & O MED LIMITED
07963347
i & o med limited directors
I & O Med Limited currently has 2 directors. The longest serving directors include Dr Omar Aldabbagh (Feb 2012) and Mrs Ibtihal Aljbouri (Sep 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Omar Aldabbagh | United Kingdom | 57 years | Feb 2012 | - | Director |
Mrs Ibtihal Aljbouri | United Kingdom | 41 years | Sep 2012 | - | Director |
P&L
February 2024turnover
3m
+30%
operating profit
230.4k
0%
gross margin
23.4%
+4.99%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
1m
+0.2%
total assets
1.3m
+0.15%
cash
0
0%
net assets
Total assets minus all liabilities
i & o med limited company details
company number
07963347
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
February 2012
age
13
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
February 2024
previous names
N/A
accountant
-
auditor
-
address
floor 2 9 portland street, manchester, M1 3BE
Bank
-
Legal Advisor
-
i & o med limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to i & o med limited.
i & o med limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for I & O MED LIMITED. This can take several minutes, an email will notify you when this has completed.
i & o med limited Companies House Filings - See Documents
date | description | view/download |
---|